Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)

CJ Rageth, EAM O'Flynn, K Pinker… - Breast cancer research …, 2019 - Springer
Abstract Purpose The second International Consensus Conference on B3 lesions was held
in Zurich, Switzerland, in March 2018, organized by the International Breast Ultrasound …

[HTML][HTML] Papillary neoplasms of the breast—reviewing the spectrum

TKY Tay, PH Tan - Modern Pathology, 2021 - Elsevier
Papillary neoplasms of the breast encompass a wide range of tumor types ranging from the
benign intraductal papilloma to in situ and invasive papillary carcinomas. In this review, we …

The incidence of adjacent synchronous invasive carcinoma and/or ductal carcinoma in situ in patients with intraductal papilloma without atypia on core biopsy: results …

F Nakhlis, GM Baker, M Pilewskie, R Gelman… - Annals of surgical …, 2021 - Springer
Background Available retrospective data suggest the upgrade rate for intraductal papilloma
(IP) without atypia on core biopsy (CB) ranges from 0 to 12%, leading to variation in …

[PDF][PDF] Benign intraductal papilloma without atypia on core needle biopsy has a low rate of upgrading to malignancy after excision

SH Han, M Kim, YR Chung, B La Yun… - Journal of breast …, 2018 - synapse.koreamed.org
Purpose: The management of benign intraductal papilloma (IDP) without atypia diagnosed
on core needle biopsy (CNB) remains controversial. This study was performed to evaluate …

Benign papillary breast mass lesions: favorable outcomes with surgical excision or imaging surveillance

G Kuehner, J Darbinian, L Habel, K Axelsson… - Annals of Surgical …, 2019 - Springer
Background There is no consensus regarding the management of benign papillary breast
lesions diagnosed on image-guided core needle biopsy (IGCNB). Methods This is a …

Analysis of 612 benign papillomas diagnosed at core biopsy: rate of upgrade to malignancy, factors associated with upgrade, and a proposal for selective surgical …

SJ Lee, RA Wahab, LD Sobel… - American Journal of …, 2021 - Am Roentgen Ray Soc
Please see the Editorial Comment by Shruthi Ram discussing this article. To listen to the
podcast associated with this article, please select one of the following: iTunes, Google Play …

Benign breast papilloma without atypia: outcomes of surgical excision versus US-guided directional vacuum-assisted removal or US follow-up

HY Choi, SM Kim, M Jang, BL Yun, E Kang, EK Kim… - Radiology, 2019 - pubs.rsna.org
Background Recent studies suggest that US-guided directional vacuum-assisted removal
(DVAR) is a satisfactory alternative to surgery for benign papilloma of the breast and …

Benign breast papillary lesions diagnosed on core biopsy: upgrade rate and risk factors associated with malignancy on surgical excision

C MacColl, A Salehi, S Parpia, N Hodgson… - Virchows Archiv, 2019 - Springer
Abstract Evaluation of radiologically detected breast lesions is a common task in surgical
pathology. Some benign lesions on biopsy are associated with an upgrade to in situ or …

Intraductal papilloma of the breast: prevalence of malignancy and natural history under active surveillance

J Limberg, W Kucher, G Fasano, S Hoda… - Annals of Surgical …, 2021 - Springer
Background The optimal management of intraductal papillomas (IPs) without atypia
diagnosed on needle core biopsy (NCB) is unclear. This study analyzed the malignancy risk …

Upgrade rate and predictive factors for breast benign intraductal papilloma diagnosed at biopsy: a meta-analysis

X Zhang, W Liu, T Hai, F Li - Annals of Surgical Oncology, 2021 - Springer
Background Current standard management for intraductal papilloma (IDP) diagnosed at
biopsy indicates complete surgical resection, but there are increasing controversies over …